Pathogen News and Research

RSS

BioFire Diagnostics submits FilmArray GI Panel to FDA for 510(k) clearance

BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration for 510(k) clearance. The comprehensive FilmArray GI Panel tests for over 20 common bacteria, viruses and parasites that cause infectious diarrhea.

18 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

Porvair Sciences to showcase specialist microplate products at Pittcon, Analytica and Genomics Research 2014

Porvair Sciences has announced that it will be showing its latest specialist microplates and microplate equipment at the forthcoming Pittcon 2014 (Chicago), Analytica 2014 (Munich) and Genomics Research 2014 (San Francisco) exhibitions.

From Chromatrap® - Porvair Sciences Ltd 11 Feb 2014

New study tracks spread of H5N1 variant in Egypt recently identified as major epicenter for virus

Since its first identification in Asia, highly pathogenic avian influenza-H5N1-has caused significant alarm in the scientific community. While the virus' primary target is birds-tens of millions have already died from it-it is capable of infecting mammals, including humans, causing serious illness and a frightening rate of mortality.

10 Feb 2014

Finding could lead to first effective vaccine against respiratory syncytial virus

Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.

9 Feb 2014

Rice, UTMB develop diagnostic test for cryptosporidiosis

Bioengineers at Rice University and the University of Texas Medical Branch (UTMB) at Galveston have developed a simple, highly sensitive and efficient test for the diarrheal disease cryptosporidiosis that could have great impact on global health.

7 Feb 2014

Study finds links between degree of urbanization and prevalence of parasites in wild house finches

Humans living in densely populated urban areas have a profound impact not only on their physical environment, but also on the health and fitness of native wildlife. For the first time, scientists have found a direct link between the degree of urbanization and the prevalence and severity of two distinct parasites in wild house finches.

6 Feb 2014

Researchers design new vaccine for human-infecting respiratory syncytial virus

Vaccines are the safest, cheapest and most effective way to protect against infectious diseases. But to make a good one is still a challenge, and traditional approaches are now stretched to the limit while fatal diseases, like HIV and malaria, remain without vaccine.

6 Feb 2014

Scientists develop fully automated system to identify sepsis in infants within hours

New detection methods could shorten the detection of sepsis from days down to only a few hours. Sepsis is a possibly mortal bacterial infection. It affects neonates and young infants more severely since their immune system is not fully developed. Now scientists are developing a fully automated system, which can identify sepsis in infants within hours instead of days.

5 Feb 2014

Llama-derived antibodies open door to development of new treatments for C. difficile infections

Researchers from the Alberta Glycomics Centre at the University of Calgary and the University of Alberta, in collaboration with researchers at the National Research Council of Canada in Ottawa, have revealed the first molecular views showing how highly specific antibodies derived from llamas may provide a new method for controlling deadly infections from the opportunistic bacterial pathogen Clostridium difficile (C. difficile).

31 Jan 2014

Scientists to develop faster method for pathogen screening in food products

The regular appearance of food poisoning in the news, including a recent event that led to the recall of more than 33,000 pounds of chicken, drives home the need for better bacterial detection long before meats and produce make it to the dinner table.

30 Jan 2014

S. pneumoniae predicts acute sinusitis microbial response

Research from the USA shows that confirmed nasopharyngeal colonization with Streptococcus pneumoniae independently predicts a rapid response to antimicrobial therapy in children with acute sinusitis.

27 Jan 2014

Sexual selection enhances ability of offspring to cope with infection

To test whether female mate choice enhances the health and disease-resistance of offspring, either through immune resistance, tolerance to infection, or both, researchers led by Dustin Penn tested female house mice's preferences (Mus musculus) for particular males and then experimentally assigned each female to mate with either their preferred or their non-preferred male.

24 Jan 2014

New technique detects bacterium that causes Legionnaires’ disease

The bacterium that causes Legionnaires’ disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.

24 Jan 2014

Compact liquid handling workstation for PCR launched by Hamilton Robotics

At the annual Society for Laboratory Automation and Screening (SLAS) conference, Hamilton Robotics has introduces the NIMBUS® PCR Workstation, which is a compact and affordable pipetting workstation enabling fast and flexible assay setup for endpoint, real-time, qPCR or multiplex PCR.

23 Jan 2014

Rice University-based research develops fast biosensor for pathogens in food

An array of tiny diving boards can perform the Olympian feat of identifying many strains of salmonella at once.

23 Jan 2014

New study raises hope to successfully fight chytridiomycosis

An international team of researchers has made important progress in understanding the distribution of the deadly amphibian chytrid pathogen. In some regions, the deadly impact of the pathogen appears to be hampered by small predators, naturally occurring in freshwater bodies. These micropredators may efficiently reduce the number of free-swimming infectious stages (zoospores) by consuming them. This natural behavior will reduce the infection pressure on potential amphibian hosts and a goes a long way towards explaining the occurrence of chytridiomycosis, at least in temporal climatic regions.

21 Jan 2014

Researchers find new candidate that may help combat malaria

Two of the most urgent challenges for scientists are the battles against food shortages and infectious diseases like malaria. Unfortunately, both the herbicides used to protect plants and the anti-infectives that shield us from disease rapidly lose their effectiveness as the target organisms develop resistance. In order to benefit both fields at once, scientists tested lead compounds from agrochemical research against infectious germs as well.

21 Jan 2014

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

How does Streptococcus pyogenes, or Group A streptococcus (GAS) — a bacterial pathogen that can colonize humans without causing symptoms or can lead to mild infections — also cause life-threatening diseases such as necrotizing fasciitis (commonly known as flesh-eating disease) and streptococcal toxic shock syndrome?

21 Jan 2014

First antigen test for human bocavirus type 1 now available on ArcDia's mariPOC test platform

ArcDia Ltd. ArcDia International Ltd today announced that the first antigen test for human bocavirus type 1 is now commercially available on ArcDia's mariPOC test platform.

21 Jan 2014

Pathogen News and Research

BioFire Diagnostics submits FilmArray GI Panel to FDA for 510(k) clearance

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Porvair Sciences to showcase specialist microplate products at Pittcon, Analytica and Genomics Research 2014

New study tracks spread of H5N1 variant in Egypt recently identified as major epicenter for virus

Finding could lead to first effective vaccine against respiratory syncytial virus

Rice, UTMB develop diagnostic test for cryptosporidiosis

Study finds links between degree of urbanization and prevalence of parasites in wild house finches

Researchers design new vaccine for human-infecting respiratory syncytial virus

Scientists develop fully automated system to identify sepsis in infants within hours

Llama-derived antibodies open door to development of new treatments for C. difficile infections

Scientists to develop faster method for pathogen screening in food products

S. pneumoniae predicts acute sinusitis microbial response

Sexual selection enhances ability of offspring to cope with infection

New technique detects bacterium that causes Legionnaires’ disease

Compact liquid handling workstation for PCR launched by Hamilton Robotics

Rice University-based research develops fast biosensor for pathogens in food

New study raises hope to successfully fight chytridiomycosis

Researchers find new candidate that may help combat malaria

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

First antigen test for human bocavirus type 1 now available on ArcDia's mariPOC test platform

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News